Correlation Between Anebulo Pharmaceuticals and Opthea

Can any of the company-specific risk be diversified away by investing in both Anebulo Pharmaceuticals and Opthea at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anebulo Pharmaceuticals and Opthea into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Anebulo Pharmaceuticals and Opthea, you can compare the effects of market volatilities on Anebulo Pharmaceuticals and Opthea and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anebulo Pharmaceuticals with a short position of Opthea. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anebulo Pharmaceuticals and Opthea.

Diversification Opportunities for Anebulo Pharmaceuticals and Opthea

0.2

Correlation Coefficient

Anebulo Pharmaceuticals  Opthea

Modest diversification

The 3 months correlation between Anebulo and Opthea is 0.2. Overlapping area represents the amount of risk that can be diversified away by holding Anebulo Pharmaceuticals and Opthea in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Opthea and Anebulo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anebulo Pharmaceuticals are associated (or correlated) with Opthea. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Opthea has no effect on the direction of Anebulo Pharmaceuticals i.e., Anebulo Pharmaceuticals and Opthea go up and down completely randomly.

Pair Corralation between Anebulo Pharmaceuticals and Opthea

Given the investment horizon of 90 days Anebulo Pharmaceuticals is expected to under-perform the Opthea. In addition to that, Anebulo Pharmaceuticals is 2.05 times more volatile than Opthea. It trades about 0.0 of its total potential returns per unit of risk. Opthea is currently generating about 0.07 per unit of volatility. If you would invest  291.00  in Opthea on August 31, 2024 and sell it today you would earn a total of  42.00  from holding Opthea or generate 14.43% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Anebulo Pharmaceuticals  vs.  Opthea

Anebulo Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Anebulo Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong technical and fundamental indicators, Anebulo Pharmaceuticals is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Opthea

Risk-Adjusted Performance

5 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Opthea are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Opthea unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Anebulo Pharmaceuticals and Opthea

The main advantage of trading using opposite Anebulo Pharmaceuticals and Opthea positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anebulo Pharmaceuticals position performs unexpectedly, Opthea can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Opthea will offset losses from the drop in Opthea's long position.

The idea behind Anebulo Pharmaceuticals and Opthea pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.